Screening Leishmania donovani complex-specific genes required for visceral disease

Methods in Molecular Biology

Volumn 1201, Issue , 2015, Pages 339-361

  Zhang, Wen Wei ^a   Matlashewski, Greg ^a  

^a NONE

Author keywords

Comparative genomics; Crossing species expression; Cutaneous leishmaniasis; Functional genomics; Gene targeting; Leishmania; Species specific genes; Tissue tropism; Transgenic expression; Virulence genes; Visceral leishmaniasis

Indexed keywords

COMPLEMENTARY RNA; GENOMIC DNA; A2 PROTEIN, LEISHMANIA DONOVANI; PARASITE ANTIGEN; PROTOZOAL PROTEIN;

ANIMAL EXPERIMENT; ARTICLE; BACTERIUM CULTURE; DNA ISOLATION; DOWN REGULATION; EXPRESSION VECTOR; GENE DELETION; GENE INACTIVATION; GENETIC SCREENING; GENETIC TRANSFECTION; LEISHMANIA DONOVANI; MOLECULAR CLONING; MOUSE; NONHUMAN; PARASITE SURVIVAL; PARASITE VIRULENCE; PRIORITY JOURNAL; PROMASTIGOTE; PROTOZOAL GENETICS; VISCERAL LEISHMANIASIS; ANIMAL; BAGG ALBINO MOUSE; FEMALE; GENETICS; LEISHMANIA MAJOR; MUTATION; PARASITOLOGY; PATHOGENICITY; TRANSGENIC ORGANISM; VIRULENCE;

LEISHMANIA BRAZILIENSIS; LEISHMANIA DONOVANI; LEISHMANIA INFANTUM; LEISHMANIA MAJOR; MUS; PROTOZOA;

ANIMALS; ANTIGENS, PROTOZOAN; FEMALE; LEISHMANIA DONOVANI; LEISHMANIA MAJOR; LEISHMANIASIS, VISCERAL; MICE, INBRED BALB C; MUTATION; ORGANISMS, GENETICALLY MODIFIED; PROTOZOAN PROTEINS; VIRULENCE;

EID: 84954591185     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4939-1438-8_20     Document Type: Article

References (25)

1. Herwaldt B (1999) Leishmaniasis. Lancet 354: 1191–1199
2. Murray H, Berman J, Davis C et al (2005) Advances in Leishmaniasis. Lancet 366: 1561–1577
3. Desjeux P (2001) The increase in risk factors for leishmaniasis worldwide. Trans R Soc Trop Med Hyg 95:239–243
4. Lipoldova M, Demant P (2006) Genetic susceptibility to infectious disease: lesions from mouse models of leishmaniasis. Nat Rev Genet 7:294–305
5. Chappuis F, Sundar S, Hailu A, Ghalib H, Rijal S, Peeling RW et al (2007) Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nat Rev Microbiol 5:873–882
6. Ivens AC, Peacock CS, Worthey EA et al (2005) The genome of the kinetoplastid parasite, Leishmania major. Science 309:436–442
7. Peacock CS, Seeger K, Harris D et al (2007) Comparative genomic analysis of three Leishmania species that cause diverse human disease. Nat Genet 39:839–847
8. Smith DF, Peacock CS, Cruz AK (2007) Comparative genomics: from genotype to disease phenotype in the leishmaniasis. Int J Parasitol 37:1173–1186
9. Rogers MB, Hilley JD, Dickens NJ et al (2011) Chromosome and gene copy number variation allow major structural change between species and strains of Leishmania. Genome Res 21: 2129–2142
10. Downing T, Imamura H, Decuypere S et al (2011) Whole genome sequencing of multiple Leishmania donovani clinical isolates provides insights into population structure and mechanisms of drug resistance. Genome Res 21: 2143–2156
11. Charest H, Matlashewski G (1994) Developmental gene expression in Leishmania donovani: differential cloning and analysis of an amastigote-stage-specific gene. Mol Cell Biol 14:2975–2984
12. Ghedin E, Zhang WW, Charest H, Sundar S, Kenney RT, Matlashewski G (1997) Antibody response against a Leishmania donovani amastigote- stage-specific protein in patients with visceral leishmaniasis. Clin Diagn Lab Immunol 4:530–535
13. Zhang WW, Matlashewski G (1997) Loss of virulence in Leishmania donovani deficient in an amastigote-specific protein, A 2. Proc Natl Acad Sci U S A 94:8807–8811
14. Zhang WW, Matlashewski G (2001) Characterization of the A2–A2rel gene cluster in Leishmania donovani: involvement of A2 in visceralization during infection. Mol Microbiol 39:935–948
15. Zhang WW, Mendez S, Ghosh A et al (2003) Comparison of the A2 gene locus in Leishmania donovani and L. major and its control over cutaneous infection. J Biol Chem 278:35508–35515
16. Zhang WW, Matlashewski G (2010) Screening Leishmania donovani -specific genes required for visceral infection. Mol Microbiol 77(2): 505–517
17. Medina-Acosta E, Cross GAM (1993) Rapid isolation of DNA from trypanosomatid protozoa using a simple “mini-prep” procedure. Mol Biochem Parasitol 59:327–329
18. Zhang WW, Charest H, Matlashewski G (1995) The expression of biologically active human p53 in Leishmania cells: a novel eukaryotic system to produce recombinant proteins. Nucleic Acids Res 23:4073–4080
19. Zhang WW, Peacock CS, Matlashewski G (2008) A genomic-based approach combining in vivo selection in mice to identify a novel virulence gene in Leishmania. PloS Negl Trop Dis 2(6):e248
20. Zhang WW, Chan KF, Song Z, Matlashewski G (2011) Expression of a Leishmaniadonovani nucleotide sugar transporter in Leishmaniamajor enhances survival in visceral organs. Exp Parasitol 129:337–345
21. Robinson KA, Beverley SM (2003) Improvements in transfection efficiency and tests of RNA interference (RNAi) approaches in the protozoan parasite Leishmania. Mol Biochem Parasitol 128:217–228
22. Papadopoulou B, Roy G, Ouellette M (1994) Autonomous replication of bacterial DNA plasmid oligomers in Leishmania. Mol Biochem Parasitol 65:39–49
23. Sambrook J, Fritsch EF, Maniatis T (1989) Molecular cloning. A laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY
24. Lye LF, Owens K, Shi H et al (2010) Retention and loss of RNA interference pathways in trypanosomatid protozoans. PLoS Pathog 6(10): e1001161
25. Papadopoulou B, Roy G, Dumas C (1997) Parameters controlling the rate of gene targeting frequency in the protozoan parasite Leishmania. Nucleic Acids Res 25:4278–4286